Navigation Links
Federal Members of Advisory Committee Block Vaccine-Autism Research, Defy Wishes of Its Own Scientists, Autism Community, and Congress
Date:1/16/2009

SafeMinds Withdraws Support for Autism Research Strategic Plan, Asks Daschle to Investigate.

WASHINGTON, Jan. 16 /PRNewswire-USNewswire/ -- In a highly unusual departure from procedure, government representatives to the Federal Interagency Autism Advisory Committee (IACC) voted this week against conducting studies on vaccine-autism research despite approval of the same studies at their prior meeting. The research was supported by numerous autism organizations and requested by IACC's scientific work groups and Congress. The maneuver to re-vote on the vaccine-autism studies was initiated by the IACC's representative from the CDC and pushed through by the IACC Chair, Dr. Tom Insel, Director of the National Institute of Mental Health of NIH.

Unlike most Federal advisory committees, the IACC is dominated by government representatives occupying 12 of the 18 seats. Of the 6 public members, 5 voted to retain the vaccine research at the meeting. The lone dissenting public member resigned from her organization, Autism Speaks, the night before the meeting. Autism Speaks has issued a statement condemning her vote.

The CDC, part of HHS along with NIH, has been criticized by parents citing failure to uphold vaccine safety. In a surprising moment of candor, Dr. Insel cited HHS conflicts of interests on vaccine-autism research due to the over 5,000 autism lawsuits pending against HHS. His comment supports the autism community's contention that those in charge of promoting vaccine use while assuring safety are fundamentally conflicted and should not investigate themselves.

IACC Member and SafeMinds Vice-President Lyn Redwood stated, "Revisiting objectives already approved did not appear on the meeting's agenda." She added, "Advocacy groups and legislators have been marginalized in this process."

Senators Enzi, Dodd, Kennedy and Santorum, as well as Representatives Barton and Smith made statements which are part of the Combating Autism Act of 2006 legislative history that research on vaccines and their components and autism should be implemented by the IACC.

Due to the IACC's actions, SafeMinds has withdrawn its support of the IACC Strategic Plan for Autism Research and requests that incoming HHS Secretary Daschle investigate the IACC's action and reconstitute the committee, including removal of NIMH as its lead agency.

SafeMinds is a private nonprofit organization that investigates and raises awareness of the risks to children of exposure to mercury from the environment and medical products, including thimerosal in vaccines.


'/>"/>
SOURCE SafeMinds
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices
2. U.S. House Acts to Protect Kids, Save Lives by Increasing Federal Tobacco Taxes
3. American Lung Association Report Card Flunks Federal Government and Most States for Neglecting to Prevent Tobacco Caused Illness
4. Zumas Rescue Ranch becomes a Federal 501C3
5. Clock Ticking for Millions of Federal Employees Hoping to Avoid Blue Cross/Blue Shield Benefits Cut
6. Riverside County Registered Nurses File a Lawsuit to Stop Countys Violation of Federal Law
7. Americans United for Life Urges State Legislatures to Oppose Federal Power Grab: Provides Model Resolution Denouncing Freedom of Choice Act (FOCA)
8. National Patient Advocate Foundation (NPAF) Announces New Executive Vice President of Federal Legislative Affairs
9. ACS Solutions for Federal Agencies: Meeting the Needs of a New Administration
10. Blue Cross/Blue Shield Christmas Gift to Federal Employees: Surprise, Were Cutting Your Benefits!; Patients, Doctors and Health Care Providers Outraged
11. Despite national guidelines, private insurers, ER, federal and state agencies fail to routinely test for HIV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Living, is proud to recognize Dr. Barry M. Weintraub as a prominent plastic ... most beautiful women in the world, and the most handsome men, look naturally ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: